Fund
ACT Venture Partners
ACT Venture Partners took part in the round of Cellbricks Therapeutics (7 M€, seed) on 27 March 2026. It is the only health round Bolus has logged for it so far.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 1
- Lead
- 0
- New entries
- 1
- Follow ons
- 0
- Latest operation
- 27 March 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 27 Mar | Germany, Biotech | Seed | 7 M€ | Participant |
Co investors 2 funds crossed
Funds that appeared in the same rounds, in any capacity. Geographies logged: Germany.